Reps. Moore and Sensenbrenner Reintroduce Bipartisan Bill to Help Advance Gastrointestinal Research

f t # e
Washington, June 20, 2019 | comments

Reps. Moore and Sensenbrenner Reintroduce Bipartisan Bill to Help Advance Gastrointestinal Research

Washington, D.C.—Today, Congresswoman Gwen Moore (WI-04) and Congressman Jim Sensenbrenner (WI-05) reintroduced The Functional Gastrointestinal and Motility Disorders Research Enhancement Act. This legislation would instruct the National Institutes of Health (NIH) to expand and coordinate research and education efforts towards Functional Gastrointestinal and Motility Disorders (FGIMD).

“Symptoms of functional gastrointestinal and motility disorders affect one’s quality of life, causing impairment or even life-threatening situations. Few effective therapies exist, which is why I am honored to join Congressman Sensenbrenner in reintroducing this bipartisan legislation to put America’s leadership in medical innovation and research toward helping the millions affected by FGIMDs. Boosting NIH research efforts to find treatments, and eventually cures, will help improve the quality and effectiveness of care for those affected by these disorders,” said Rep. Moore.

“Many individuals living with functional gastrointestinal and motility disorders have few, if any, effective treatments available to them. By expanding our efforts and prioritizing FGIMD research, I’m confident that we can find meaningful ways to improve life for those living with these disorders. I’m pleased to collaborate on this bipartisan effort with Congresswoman Moore.  It is important that individuals affected by FGIMDs know that we are working hard on this important issue,” said Rep. Sensenbrenner.

Background:

Functional gastrointestinal and motility disorders are among the most common health disorders in the general population. These conditions can affect any part of the digestive tract, including the esophagus, stomach, and the small and large intestines. FGIMDs are typically classified by symptoms related to any combination of the following: motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota, and altered central nervous system (CNS) processing.

Treatment generally focuses on management of complex symptoms over a long term. Some examples of functional gastrointestinal disorders are: dyspepsia, gastroparesis, irritable bowel syndrome, gastroesophageal reflux disease, bowel incontinence, and cyclic vomiting syndrome. Patients with FGIMDs can suffer for years before receiving a diagnosis and only have access to few effective treatments due to a lack of proper education for physicians.

f t # e

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.